N-[2-(furan-2-yl)-5-oxo-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-2-phenylquinoline-4-carboxamide
C25H16N6O3 — CID 135472206
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(furan-2-yl)-5-oxo-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-2-phenylquinoline-4-carboxamide
N-[2-(furan-2-yl)-5-oxo-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-2-phenylquinoline-4-carboxamide (PubChem CID 135472206) has the molecular formula C25H16N6O3 and a molecular weight of 448.44 g/mol. Its IUPAC name is N-[2-(furan-2-yl)-5-oxo-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-2-phenylquinoline-4-carboxamide.
Molecular Properties
| Compound Name | N-[2-(furan-2-yl)-5-oxo-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-2-phenylquinoline-4-carboxamide |
|---|---|
| PubChem CID | 135472206 |
| Molecular Formula | C25H16N6O3 |
| Molecular Weight | 448.44 g/mol |
| Exact Mass | 448.13 |
| IUPAC Name | N-[2-(furan-2-yl)-5-oxo-4H-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]-2-phenylquinoline-4-carboxamide |
| SMILES | O=C(Nc1cc(=O)[nH]c2nc(-c3ccco3)nn12)c1cc(-c2ccccc2)nc2ccccc12 |
| InChI | InChI=1S/C25H16N6O3/c32-22-14-21(31-25(28-22)29-23(30-31)20-11-6-12-34-20)27-24(33)17-13-19(15-7-2-1-3-8-15)26-18-10-5-4-9-16(17)18/h1-14H,(H,27,33)(H,28,29,30,32) |
| InChIKey | QVTMRXGRAVDDOH-UHFFFAOYSA-N |
| XLogP | 4.15 |
| TPSA | 118.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 448.44 |
| LogP ≤ 5 | 4.15 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135472206 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.